Prot #ATYR1923-C-002: A Randomized, Double-Blind, Placebo-Controlled Multiple Ascending Dose Study of Intravenous ATYR1923 in Patients with Pulmonary Sarcoidosis

Project: Research project

StatusActive
Effective start/end date2/4/192/4/22

Funding

  • aTyr Pharma, Inc. (Prot #ATYR1923-C-002)